Duflot Thomas

Has grant

Associate Professor

INSERM

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Duflot Thomas is an Associate Professor at INSERM in France, where he focuses on pharmacokinetics, diabetes-related vascular complications, and gastrointestinal disorders. His recent research includes studies on anal sphincter function, bowel symptoms in multiple sclerosis, and the effects of obesity on cardiac health. Dr. Thomas has published extensively on topics related to drug metabolism in critically ill patients and the physiological implications of various enzymatic pathways.

Recent Grants

Grant: Close

Research year

Open Date:

Close Date:

Grant: Close

Gold medal

Open Date:

Close Date:

Articles (14)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Alexis Chenouard

Université de Nantes

FRANCE

View details

Serge Luquet

Université Paris Cité

FRANCE

View details

Carlos Afonso

Professor

University of Rouen

FRANCE

View details

Bellien Jeremy

Professor of Pharmacology, PharmD, PhD

INSERM U1065

FRANCE

View details

Ahmed Karoui

associate professor

Université Paris-Saclay

FRANCE

View details

Déborah Groussard

Institut Pasteur

FRANCE

View details

Valéry Brunel

Praticien Hospitalier, Pharm D, Head of Department

FRANCE

View details

Gilles Rautureau

Professor

Université Claude Bernard Lyon 1 Faculté des Sciences et Technologies

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Duflot Thomas

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (14)

Dynamic functional luminal imaging probe analysis of the anal sphincter opening function during straining in healthy volunteers

Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats

Correction to: Population Pharmacokinetics of Levosimendan and its Metabolites in Critically Ill Neonates and Children Supported or Not by Extracorporeal Membrane Oxygenation

Population Pharmacokinetics of Levosimendan and its Metabolites in Critically Ill Neonates and Children Supported or Not by Extracorporeal Membrane Oxygenation

Multiple sclerosis and bowel symptoms: Frequency and barriers to their management

Changes in carotid arterial wall viscosity and carotid arterial stiffness in type 2 diabetes patients

Determination of Lipoxygenase, CYP450, and Non-Enzymatic Metabolites of Arachidonic Acid in Essential Hypertension and Type 2 Diabetes

CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury

Relationship between anal functional lumen imaging probe (EndoFLIP®) results and the clinical presentation of faecal incontinence

Pharmacokinetic modeling of morphine and its glucuronides: Comparison of nebulization versus intravenous route in healthy volunteers

Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?

Preservation of epoxyeicosatrienoic acid bioavailability prevents renal allograft dysfunction and cardiovascular alterations in kidney transplant recipients.

Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review

Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal Syndrome

Collaborators (8)

Alexis Chenouard

Serge Luquet

Carlos Afonso

Bellien Jeremy

Ahmed Karoui

Déborah Groussard

Valéry Brunel

Gilles Rautureau

Make your next move.